| PHM |
Report |
EPS |
IN-LINE |
pred ~$2.34 vs. cons $2.36 |
MEDIUM |
| PHM |
Report |
Net new orders |
MISS |
pred ~7,150 homes vs. cons 7,383 homes |
MEDIUM |
| PHM |
Report |
Home sale gross margin |
IN-LINE |
pred ~24.2% vs. cons 24.3% |
MEDIUM |
| PHM |
Guide |
FY26 closings |
LOWER |
guide ~28,250 homes vs. cons 28,750 homes (FY2026) |
MEDIUM |
| PHM |
Guide |
FY26 average selling price |
UNCHANGED |
guide ~$555,000 vs. cons $555,000 (FY2026) |
MEDIUM |
| PHM |
Guide |
FY26 home sale gross margin |
UNCHANGED |
guide ~24.7% vs. cons 24.7% (FY2026) |
MEDIUM |
| PHM |
Guide |
FY26 operating cash flow |
LOWER |
guide ~$0.9B vs. cons $1.0B (FY2026) |
LOW |
| PHM |
Return |
Day-1 residual (stock − beta × S&P 500) |
-5.5% |
— |
MEDIUM |
| PHM |
Return |
5-day cumulative residual |
-7.5% (FOLLOW-THROUGH) |
A ~500-home FY26 closing-guide cut versus the prior ~28,750-home expectation and softer ~7,150 orders versus 7,383 consensus would outweigh an essentially in-line ~$2.34 EPS result. The reduced delivery base implies lower 2H26 volume and pulls FY27 revenue/EPS math lower despite broadly preserved ~24.7% FY26 gross-margin guidance. |
MEDIUM |